Menu
Nifty
Sensex
:
:
22535.85
74227.08
374.25 (1.69%)
1089.18 (1.49%)

Pharmaceuticals & Drugs - Veterinary

Rating :
N/A

BSE: 512529 | NSE: SEQUENT

163.02
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  167.88
  •  167.99
  •  162.00
  •  164.36
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  255735
  •  418.80
  •  240.70
  •  92.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,425.38
  • 294.05
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,802.97
  • N/A
  • 4.95

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.61%
  • 2.92%
  • 23.82%
  • FII
  • DII
  • Others
  • 6.1%
  • 9.58%
  • 4.97%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.40
  • 3.04
  • -1.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.60
  • -18.46
  • -10.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.82
  • -50.72
  • -65.27

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.65
  • 57.59
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.18
  • 5.12
  • 4.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 44.30
  • 59.01
  • 82.03

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
0.03
P/E Ratio
6606
Revenue
158
EBITDA
-27
Net Income
1
ROA
0.1
P/B Ratio
4.55
ROE
0.06
FCFF
-44.98
FCFF Yield
-0.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
390.81
329.36
18.66%
368.65
345.97
6.56%
390.21
333.21
17.11%
361.20
366.67
-1.49%
Expenses
356.31
307.11
16.02%
329.55
330.84
-0.39%
348.26
341.45
1.99%
328.93
370.04
-11.11%
EBITDA
34.50
22.25
55.06%
39.10
15.13
158.43%
41.95
-8.24
-
32.27
-3.37
-
EBIDTM
8.83%
6.76%
10.61%
4.37%
10.75%
-2.47%
8.93%
-0.92%
Other Income
5.84
4.52
29.20%
4.51
1.65
173.33%
2.68
0.79
239.24%
4.00
1.74
129.89%
Interest
14.95
12.58
18.84%
14.29
12.58
13.59%
16.38
10.48
56.30%
12.44
10.87
14.44%
Depreciation
16.98
15.46
9.83%
17.10
15.36
11.33%
16.25
14.24
14.12%
16.48
14.71
12.03%
PBT
8.10
1.49
443.62%
7.90
-3.09
-
12.00
-55.68
-
2.64
-88.80
-
Tax
1.62
-9.19
-
1.56
3.79
-58.84%
2.94
-21.00
-
1.36
3.64
-62.64%
PAT
6.48
10.68
-39.33%
6.34
-6.88
-
9.06
-34.68
-
1.27
-92.44
-
PATM
1.66%
3.24%
1.72%
-1.99%
2.32%
-10.41%
0.35%
-25.21%
EPS
0.14
0.33
-57.58%
0.10
-0.34
-
0.26
-1.40
-
-0.04
-0.04
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,510.87
1,369.73
1,420.91
1,412.82
1,361.62
1,179.24
1,039.31
1,030.59
683.57
624.98
465.36
Net Sales Growth
9.86%
-3.60%
0.57%
3.76%
15.47%
13.46%
0.85%
50.77%
9.37%
34.30%
 
Cost Of Goods Sold
806.65
759.74
833.77
793.00
694.65
605.05
543.01
554.23
356.70
311.71
240.72
Gross Profit
704.22
609.98
587.14
619.82
666.96
574.19
496.30
476.36
326.87
313.27
224.65
GP Margin
46.61%
44.53%
41.32%
43.87%
48.98%
48.69%
47.75%
46.22%
47.82%
50.12%
48.27%
Total Expenditure
1,363.05
1,308.32
1,408.95
1,303.43
1,151.68
1,008.92
914.37
919.10
643.03
568.27
444.87
Power & Fuel Cost
-
35.46
42.45
33.86
28.75
24.73
23.06
14.66
12.77
26.51
23.32
% Of Sales
-
2.59%
2.99%
2.40%
2.11%
2.10%
2.22%
1.42%
1.87%
4.24%
5.01%
Employee Cost
-
250.57
258.38
231.37
187.22
165.06
145.95
132.07
106.22
88.62
62.39
% Of Sales
-
18.29%
18.18%
16.38%
13.75%
14.00%
14.04%
12.81%
15.54%
14.18%
13.41%
Manufacturing Exp.
-
73.58
86.95
93.67
96.18
83.24
77.73
59.07
57.63
72.14
54.31
% Of Sales
-
5.37%
6.12%
6.63%
7.06%
7.06%
7.48%
5.73%
8.43%
11.54%
11.67%
General & Admin Exp.
-
78.10
75.80
66.90
58.40
56.37
58.35
70.92
48.60
36.44
33.79
% Of Sales
-
5.70%
5.33%
4.74%
4.29%
4.78%
5.61%
6.88%
7.11%
5.83%
7.26%
Selling & Distn. Exp.
-
56.70
58.00
57.11
50.00
45.16
36.29
36.87
28.78
17.46
20.27
% Of Sales
-
4.14%
4.08%
4.04%
3.67%
3.83%
3.49%
3.58%
4.21%
2.79%
4.36%
Miscellaneous Exp.
-
54.16
53.60
27.52
36.47
29.32
29.98
51.29
32.34
15.40
20.27
% Of Sales
-
3.95%
3.77%
1.95%
2.68%
2.49%
2.88%
4.98%
4.73%
2.46%
2.16%
EBITDA
147.82
61.41
11.96
109.39
209.94
170.32
124.94
111.49
40.54
56.71
20.49
EBITDA Margin
9.78%
4.48%
0.84%
7.74%
15.42%
14.44%
12.02%
10.82%
5.93%
9.07%
4.40%
Other Income
17.03
10.96
6.39
10.86
10.49
10.09
8.67
17.20
11.08
14.30
9.96
Interest
58.06
48.09
35.52
15.77
24.38
35.71
32.80
39.70
28.34
38.56
44.37
Depreciation
66.81
61.54
55.69
51.54
50.60
50.62
41.92
53.30
40.07
46.22
32.94
PBT
30.64
-37.26
-72.86
52.93
145.45
94.08
58.88
35.70
-16.80
-13.77
-46.85
Tax
7.48
-25.03
-15.68
8.17
32.18
12.03
2.01
13.46
-0.41
2.62
3.39
Tax Rate
24.41%
45.80%
11.39%
15.44%
23.55%
12.79%
3.41%
3.03%
2.44%
-19.03%
-40.50%
PAT
23.15
-35.87
-121.16
40.95
95.44
69.91
48.66
421.57
-13.83
-18.47
-10.74
PAT before Minority Interest
11.64
-29.61
-121.98
44.76
104.45
82.05
56.88
430.83
-16.39
-16.39
-11.76
Minority Interest
-11.51
-6.26
0.82
-3.81
-9.01
-12.14
-8.22
-9.26
2.56
-2.08
1.02
PAT Margin
1.53%
-2.62%
-8.53%
2.90%
7.01%
5.93%
4.68%
40.91%
-2.02%
-2.96%
-2.31%
PAT Growth
118.77%
-
-
-57.09%
36.52%
43.67%
-88.46%
-
-
-
 
EPS
0.92
-1.43
-4.84
1.64
3.81
2.79
1.94
16.84
-0.55
-0.74
-0.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
656.56
698.78
692.10
727.65
687.10
706.69
647.58
976.79
945.71
91.27
Share Capital
49.89
49.89
49.67
49.67
49.67
49.37
48.75
48.75
47.65
30.48
Total Reserves
529.37
592.57
595.33
670.21
623.34
638.43
581.25
912.49
874.01
26.85
Non-Current Liabilities
122.08
175.81
209.11
153.58
216.46
214.75
227.13
246.20
299.72
277.55
Secured Loans
123.76
113.95
87.25
62.52
108.88
126.94
85.14
141.76
197.50
249.97
Unsecured Loans
18.96
36.16
35.21
31.18
41.18
20.90
18.40
23.38
13.82
0.35
Long Term Provisions
21.75
21.47
55.95
27.19
13.16
30.50
28.54
34.76
28.66
25.70
Current Liabilities
626.99
558.76
537.35
513.11
514.86
440.41
430.93
663.55
290.37
406.09
Trade Payables
260.26
244.34
258.05
226.91
220.38
209.35
160.49
203.04
143.94
90.94
Other Current Liabilities
109.56
109.57
78.99
100.64
104.98
87.80
106.52
259.26
83.23
107.43
Short Term Borrowings
245.87
182.09
159.54
102.91
147.12
127.36
152.41
194.70
56.04
204.31
Short Term Provisions
11.31
22.76
40.77
82.66
42.38
15.90
11.51
6.54
7.17
3.42
Total Liabilities
1,462.03
1,483.76
1,486.57
1,443.00
1,463.16
1,402.10
1,342.62
1,903.76
1,538.02
921.84
Net Block
591.95
605.31
564.44
535.66
576.57
498.14
475.97
684.33
586.48
474.43
Gross Block
959.12
939.83
825.09
753.25
762.46
638.06
581.74
789.60
643.70
596.25
Accumulated Depreciation
367.17
334.52
260.64
217.60
185.89
139.91
105.77
105.27
57.22
121.82
Non Current Assets
639.17
693.88
678.16
676.33
738.86
795.99
804.61
1,176.02
1,047.48
612.00
Capital Work in Progress
15.93
55.28
11.63
30.79
13.42
22.61
18.04
32.55
23.52
39.06
Non Current Investment
0.89
0.01
36.79
76.94
131.29
179.65
221.73
363.97
360.58
58.04
Long Term Loans & Adv.
18.99
21.74
53.92
32.15
14.40
32.27
31.01
37.51
30.35
36.01
Other Non Current Assets
11.41
11.54
11.37
0.79
3.18
63.31
57.86
57.66
46.54
4.47
Current Assets
810.94
779.79
808.41
766.68
724.30
606.12
538.01
727.74
490.54
309.84
Current Investments
2.61
0.05
1.44
5.66
40.18
0.47
17.34
64.12
66.98
0.58
Inventories
346.23
346.09
347.97
264.36
219.42
200.10
158.57
160.81
135.08
94.36
Sundry Debtors
335.63
340.96
329.24
346.14
318.76
278.25
258.35
254.62
192.39
115.44
Cash & Bank
69.83
41.75
59.25
56.20
75.83
72.04
42.45
47.40
25.30
38.46
Other Current Assets
56.63
7.74
7.68
16.82
70.12
55.26
61.30
200.79
70.80
61.01
Short Term Loans & Adv.
46.26
43.21
62.83
77.52
55.33
46.75
56.05
54.48
46.69
41.86
Net Current Assets
183.95
221.03
271.06
253.57
209.44
165.71
107.08
64.19
200.17
-96.25
Total Assets
1,450.11
1,473.67
1,486.57
1,443.01
1,463.16
1,402.11
1,342.62
1,903.76
1,538.02
921.84

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
30.59
16.81
30.59
114.75
115.33
116.02
45.24
-7.19
-0.05
-23.55
PBT
-54.65
-137.66
52.93
145.45
94.08
58.88
445.79
-16.80
-13.77
-8.37
Adjustment
144.97
220.72
93.73
83.98
91.41
84.47
-313.85
123.31
83.81
35.92
Changes in Working Capital
-45.67
-51.61
-89.30
-70.89
-58.30
-27.95
-77.87
-104.37
-71.46
-53.98
Cash after chg. in Working capital
44.65
31.45
57.36
158.55
127.18
115.40
54.06
2.14
-1.42
-26.44
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.06
-14.64
-26.77
-43.79
-11.85
0.62
-8.83
-9.33
1.37
2.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.92
-64.96
-95.57
9.65
-72.27
-67.69
7.17
-116.18
-315.83
-154.69
Net Fixed Assets
20.87
1.33
-7.29
-4.18
-29.66
-32.63
221.87
-49.63
97.97
38.51
Net Investments
-7.89
26.09
26.57
72.52
30.56
-101.61
210.25
0.26
-713.97
-118.07
Others
-18.90
-92.38
-114.85
-58.69
-73.17
66.55
-424.95
-66.81
300.17
-75.13
Cash from Financing Activity
-1.44
32.23
67.26
-138.75
-42.75
-20.08
-56.96
147.44
308.69
179.41
Net Cash Inflow / Outflow
23.24
-15.92
2.29
-14.35
0.31
28.25
-4.55
24.07
-7.19
1.17
Opening Cash & Equivalents
41.57
57.50
53.74
68.10
67.79
39.54
44.10
20.03
21.85
22.96
Closing Cash & Equivalent
64.81
41.57
57.50
53.74
68.10
67.79
39.54
44.10
20.03
21.83

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
23.22
25.76
25.97
28.98
27.10
27.86
25.85
39.44
38.69
3.76
ROA
-2.01%
-8.21%
3.06%
7.19%
5.73%
4.14%
26.54%
-0.95%
-1.33%
-1.52%
ROE
-4.85%
-18.95%
6.56%
15.00%
12.06%
8.63%
54.15%
-1.74%
-3.35%
-28.10%
ROCE
-0.60%
-9.71%
7.01%
16.24%
12.59%
9.24%
41.28%
0.87%
2.72%
6.93%
Fixed Asset Turnover
1.49
1.65
1.83
1.80
1.72
1.74
1.51
0.96
1.03
1.01
Receivable days
87.51
84.11
85.48
89.12
90.45
92.53
90.49
118.40
87.75
74.80
Inventory Days
89.54
87.10
77.50
64.84
63.56
61.85
56.34
78.37
65.41
73.58
Payable days
121.21
109.97
111.61
117.51
80.72
75.36
77.04
104.11
77.28
87.31
Cash Conversion Cycle
55.84
61.25
51.38
36.45
73.29
79.02
69.78
92.66
75.87
61.07
Total Debt/Equity
0.78
0.62
0.49
0.31
0.51
0.47
0.48
0.43
0.34
8.26
Interest Cover
-0.14
-2.88
4.36
6.60
3.63
2.80
12.19
0.41
0.64
0.81

News Update:


  • Sequent Scientific reports 39% fall in Q3 consolidated net profit
    11th Feb 2025, 17:00 PM

    Total consolidated income of the company decreased by 9.81% at Rs 1503.16 crore for Q3FY25

    Read More
  • Sequent Scientific - Quarterly Results
    11th Feb 2025, 13:13 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.